Cargando…
Pharmacology before, during and after percutaneous coronary intervention
Autores principales: | Zaman, Azfar G, Aleem, Qaiser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958112/ https://www.ncbi.nlm.nih.gov/pubmed/33148548 http://dx.doi.org/10.1136/heartjnl-2019-315090 |
Ejemplares similares
-
Cyclic ST-segment elevation after primary percutaneous coronary intervention
por: Jansen, W. P. J.
Publicado: (2020) -
Timing and completeness of revascularisation in acute coronary syndromes
por: Sanz-Sánchez, Jorge, et al.
Publicado: (2022) -
Optimal management of acute coronary syndromes in the era of COVID-19
por: Nijjer, Sukhjinder Singh, et al.
Publicado: (2020) -
Acute pontine infarction after percutaneous coronary intervention: a very rare but devastating complication
por: Arslan, F., et al.
Publicado: (2015) -
Coronary physiological assessment in the catheter laboratory: haemodynamics, clinical assessment and future perspectives
por: Morris, Paul D, et al.
Publicado: (2022)